Months after Sens. Cory Booker (D-NJ) and Rand Paul (R-KY) introduced a bill that would expand access to Schedule I drugs for terminally ill patients,...
Filament Health Corp. (OTCQB: FLHLF | NEO: FH) (FSE: 7QS), a clinical‐stage natural psychedelic drug development company, today announced an agreement...
The Dentinger Lab at the Natural History Museum of Utah has published a provocative new paper in the journal New Phytologist that describes their work...
The Covid-19 pandemic shifted the economy in many ways. Some industries and practices became nearly obsolete. Other industries have seen exponential growth....
The results of the company’s Phase 2b trial raise concerns around safety, efficacy, and money, suggesting key questions to be addressed in Phase 3. The...
The psychedelics research company ended the quarter with less than $100K cash. The post Mydecine Continues Cash Burn through Q3 appeared first on Green...
You may have never heard of psilacetin. In fact, when you first saw it, it may have confused you. “Is this a misspelling of psilocybin? Is...
ReMind Psychedelics Business Forum was held Nov. 15 in Las Vegas. The post A Psychedelics Forum: How the Industry is Evolving into Tomorrow appeared first...
The article Elon Talks Psychedelics: Is he Helping or Hurting the Movement? was originally published on Microdose. “Amphetamines negatively affect empathy,...
In this edition of Mindshifting Moments, Margaret Williamson is joined by Todd Shapiro and Sarah Hashkes of Red Light Holland. The conversation answers...